We are live on
!
Find out more
FAM
Fred Alger Management Portfolio holdings
AUM
$22.8B
1-Year Est. Return
64.63%
This Fund
S&P 500
This Quarter
Est. Return
+17.72%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$18.5B
AUM Growth
+$1.14B
(+6.5%)
Cap. Flow
-$1.33B
Cap. Flow
% of AUM
-7.2%
Top 10 Holdings %
Top 10 Hldgs %
39.28%
Holding
503
New
42
Increased
140
Reduced
229
Closed
60
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$91.1M |
| 2 |
Advanced Micro Devices
AMD
|
+$86.6M |
| 3 |
Broadcom
AVGO
|
+$78.2M |
| 4 |
Vertiv
VRT
|
+$76.7M |
| 5 |
Burlington
BURL
|
+$42.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$142M |
| 2 |
Trip.com Group
TCOM
|
+$101M |
| 3 |
Tesla
TSLA
|
+$87.5M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$83.1M |
| 5 |
Trade Desk
TTD
|
+$80.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.38% |
| 2 | Healthcare | 19.58% |
| 3 | Consumer Discretionary | 11.08% |
| 4 | Industrials | 10.46% |
| 5 | Communication Services | 10.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AKRO
326
DELISTED
Akero Therapeutics
AKRO
| $2.12M | 0.01% |
90,812
-350,274
| -79% | -$6.91M |
|
|
HLVX
327
DELISTED
HilleVax
HLVX
| $2.11M | 0.01% |
131,447
+10,813
| +9% | +$144K |
|
328
Johnson Controls International
JCI
$85.1B
| $2.09M | 0.01% |
36,340
+2,238
| +7% | +$117K |
|
329
Bristol-Myers Squibb
BMY
$129B
| $2.08M | 0.01% |
40,530
+305
| +0.8% | +$16K |
|
|
CYBR
330
DELISTED
CyberArk
CYBR
| $2.06M | 0.01% |
9,382
+26
| +0.3% | +$4.82K |
|
331
Privia Health
PRVA
$3.04B
| $2.05M | 0.01% |
88,877
-917
| -1% | -$20.5K |
|
332
Global Payments
GPN
$24.1B
| $2.03M | 0.01% |
15,998
-3,190
| -17% | -$369K |
|
333
Vail Resorts
MTN
$5.7B
| $2.01M | 0.01% |
9,438
| – | – |
|
334
Teleflex
TFX
$5.96B
| $1.95M | 0.01% |
7,804
-12,605
| -62% | -$2.69M |
|
335
Blackstone Mortgage Trust
BXMT
$2.77B
| $1.93M | 0.01% |
90,670
+7,124
| +9% | +$154K |
|
336
Elanco Animal Health
ELAN
$13.2B
| $1.92M | 0.01% |
129,077
-491,787
| -79% | -$5.57M |
|
337
MaxCyte
MXCT
$108M
| $1.91M | 0.01% |
407,096
+46,222
| +13% | +$180K |
|
|
MORF
338
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $1.9M | 0.01% |
65,649
-67,096
| -51% | -$1.6M |
|
339
Gilead Sciences
GILD
$165B
| $1.78M | 0.01% |
22,003
+1,165
| +6% | +$90.7K |
|
340
Cytokinetics
CYTK
$10.6B
| $1.75M | 0.01% |
+20,921
| New | +$758K |
|
341
Oscar Health
OSCR
$9.22B
| $1.73M | 0.01% |
189,307
+21,675
| +13% | +$150K |
|
342
Salesforce
CRM
$154B
| $1.67M | 0.01% |
6,348
-705
| -10% | -$160K |
|
343
General Dynamics
GD
$103B
| $1.66M | 0.01% |
6,410
+61
| +1% | +$14.9K |
|
344
WillScot Mobile Mini Holdings
WSC
$4.37B
| $1.65M | 0.01% |
37,139
-114,668
| -76% | -$4.63M |
|
345
CAVA Group
CAVA
$7.61B
| $1.63M | 0.01% |
37,833
-469
| -1% | -$16.4K |
|
|
MRTX
346
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $1.58M | 0.01% |
+26,977
| New | +$1.52M |
|
347
Rivian
RIVN
$23.6B
| $1.52M | 0.01% |
64,713
-302,613
| -82% | -$5.69M |
|
348
Forte Biosciences
FBRX
$1.57B
| $1.51M | 0.01% |
73,559
| – | – |
|
|
MASI
349
DELISTED
Masimo
MASI
| $1.46M | 0.01% |
+12,439
| New | +$1.16M |
|
350
XPO
XPO
$23.4B
| $1.44M | 0.01% |
16,447
-3,188
| -16% | -$260K |
|
Similar funds
CAM
BA
AM
SAM
CHP
Fred Alger Management's Q4 2023 Portfolio in Review
As of Q4 2023, Fred Alger Management held 503 positions worth $18.5B, up 6.5% from $17.4B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Fred Alger Management withdrew a net $1.33B in Q4 2023, closing 60 positions and reducing 229 holdings. Its most notable exit was Albemarle, an estimated $77.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 37% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Fred Alger Management opened a new position in Micron Technology worth $35.6M.
- Fred Alger Management's largest Q4 2023 buy was Micron Technology: 417,196 shares worth $35.6M.
- Fred Alger Management added most to Amgen in Q4 2023, an estimated $91.1M increase.
- Fred Alger Management's biggest Q4 2023 reduction was NVIDIA, cutting an estimated $142M.
- Fred Alger Management fully exited Albemarle in Q4 2023, selling an estimated $77.2M.
- Fred Alger Management's ten largest holdings make up 39% of its $18.5B portfolio in Q4 2023.
- Fred Alger Management opened 42 new positions and closed 60 in Q4 2023.
- Fred Alger Management's portfolio value rose 6.5% quarter-over-quarter to $18.5B.
Based on Fred Alger Management's 13F filing for Q4 2023, filed 14 Feb 2024.